111 related articles for article (PubMed ID: 11115600)
1. Dynamics of circadian fluctuations in serum concentration of cortisol and TNF-alpha soluble receptors in gastrointestinal cancer patients.
Zubelewicz-Szkodzinska B; Muc-Wierzgon M; Wierzgon J; Brodziak A
Oncol Rep; 2001; 8(1):207-12. PubMed ID: 11115600
[TBL] [Abstract][Full Text] [Related]
2. Circadian fluctuations of melatonin, tumor necrosis factor-alpha and its soluble receptors in the circulation of patients with advanced gastrointestinal cancer.
Muc-Wierzgon M; Nowakowska-Zajdel E; Zubelewicz B; Wierzgon J; Kokot T; Klakla K; Szkilnik R; Wiczkowski A
J Exp Clin Cancer Res; 2003 Jun; 22(2):171-8. PubMed ID: 12866566
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of diurnal changes in serum concentration of TNF-alpha soluble receptors in gastrointestinal cancer patients.
Muc-Wierzgoń M; Baranowski MM; Madej K; Wierzgoń J; Kokot T; Brodziak A
J Biol Regul Homeost Agents; 2000; 14(3):204-8. PubMed ID: 11037054
[TBL] [Abstract][Full Text] [Related]
4. The estimation of endogenous tumor necrosis factor alpha and cortisol levels in serum in advanced neoplasm.
Baranowski M; Muc-Wierzgon M; Madej K; Wierzgoń J; Zubelewicz B
J Exp Clin Cancer Res; 1999 Jun; 18(2):241-5. PubMed ID: 10464714
[TBL] [Abstract][Full Text] [Related]
5. Is there a correlation between tumor necrosis factor alpha and soluble p-55 receptor plasma levels in advanced gastrointestinal cancer patients?
Muc-Wierzgoń M; Madej K; Baranowski M; Wierzgoń J
J Biol Regul Homeost Agents; 1996; 10(4):95-7. PubMed ID: 9604778
[TBL] [Abstract][Full Text] [Related]
6. Circadian rhythm of the soluble p75 tumor necrosis factor (sTNF-R75) receptor in humans--a possible explanation for the circadian kinetics of TNR-alpha effects.
Liebmann PM; Reibnegger G; Lehofer M; Moser M; Pürstner P; Mangge H; Schauenstein K
Int Immunol; 1998 Sep; 10(9):1393-6. PubMed ID: 9786439
[TBL] [Abstract][Full Text] [Related]
7. Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer.
Shibata M; Takekawa M; Amano S
Surg Today; 1998; 28(9):884-8. PubMed ID: 9744395
[TBL] [Abstract][Full Text] [Related]
8. Fluctuation of endogenous TNF alpha concentration in plasma in advanced cancer patients.
Muc-Wierzgoń M; Madej K; Baranowski M; Kokot T
J Biol Regul Homeost Agents; 1996; 10(1):25-6. PubMed ID: 9049778
[TBL] [Abstract][Full Text] [Related]
9. Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls.
Raida M; Kliche KO; Schwabe W; Häusler P; Clement JH; Behnke D; Höffken K
J Cancer Res Clin Oncol; 2002 Feb; 128(2):96-102. PubMed ID: 11862480
[TBL] [Abstract][Full Text] [Related]
10. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers.
Haack M; Pollmächer T; Mullington JM
Brain Behav Immun; 2004 Jul; 18(4):361-7. PubMed ID: 15157953
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
[TBL] [Abstract][Full Text] [Related]
12. Elevated blood levels of soluble tumor necrosis factor receptors in nasopharyngeal carcinoma: correlation with humoral immune response to lytic replication of Epstein-Barr virus.
Feng P; Chan SH; Ooi EE; Soo MY; Loh KS; Wang D; Ren EC; Hu H
Int J Oncol; 1999 Jul; 15(1):167-72. PubMed ID: 10375611
[TBL] [Abstract][Full Text] [Related]
13. Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.
Barber MD; Fearon KC; Ross JA
Clin Sci (Lond); 1999 Jan; 96(1):83-7. PubMed ID: 9857110
[TBL] [Abstract][Full Text] [Related]
14. Circadian rhythmometry of serum endogenous tumor necrosis factor-alpha in patients with colorectal cancer metastases.
Muc-Wierzgoń M; Madej K; Baranowski M; Wierzgoń J
Eur Cytokine Netw; 1998 Jun; 9(2):193-6. PubMed ID: 9681396
[TBL] [Abstract][Full Text] [Related]
15. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
[TBL] [Abstract][Full Text] [Related]
16. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronic hepatitis C.
Fabris C; Del Forno M; Falleti E; Toniutto P; Pirisi M
Clin Exp Immunol; 1999 Sep; 117(3):556-60. PubMed ID: 10469062
[TBL] [Abstract][Full Text] [Related]
18. [Expression of lymphocyte activation markers in patients with gastrointestinal tumors at different stages].
Oleĭnik EK; Shibaev MI; Oleĭnik VM
Vopr Onkol; 2005; 51(5):571-4. PubMed ID: 16756013
[TBL] [Abstract][Full Text] [Related]
19. Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men.
Haack M; Reichenberg A; Kraus T; Schuld A; Yirmiya R; Pollmächer T
Cytokine; 2000 Jun; 12(6):694-8. PubMed ID: 10843747
[TBL] [Abstract][Full Text] [Related]
20. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?
Rostoker G; Rymer JC; Bagnard G; Petit-Phar M; Griuncelli M; Pilatte Y
Clin Exp Immunol; 1998 Dec; 114(3):468-76. PubMed ID: 9844059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
